NO20061138L - Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi - Google Patents

Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi

Info

Publication number
NO20061138L
NO20061138L NO20061138A NO20061138A NO20061138L NO 20061138 L NO20061138 L NO 20061138L NO 20061138 A NO20061138 A NO 20061138A NO 20061138 A NO20061138 A NO 20061138A NO 20061138 L NO20061138 L NO 20061138L
Authority
NO
Norway
Prior art keywords
glycemia
hyperglycemia
prevention
treatment
stabilize
Prior art date
Application number
NO20061138A
Other languages
English (en)
Inventor
Lucien Lesaffre
Original Assignee
Lesaffre & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lesaffre & Cie filed Critical Lesaffre & Cie
Publication of NO20061138L publication Critical patent/NO20061138L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Den foreliggende oppfinnelse angår behandlingen og forebyggingen av hyperglykemi og stabiliseringen av glykemi.
NO20061138A 2003-08-11 2006-03-09 Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi NO20061138L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03018222 2003-08-11
EP03020253 2003-09-08
PCT/EP2004/008933 WO2005021015A1 (fr) 2003-08-11 2004-08-10 Ecorces de levures pour le traitement ou la prevention de l’hyperglycemie ou pour la stabilisation de la glycemie

Publications (1)

Publication Number Publication Date
NO20061138L true NO20061138L (no) 2006-05-10

Family

ID=34276722

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061138A NO20061138L (no) 2003-08-11 2006-03-09 Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi

Country Status (17)

Country Link
US (2) US7459159B2 (no)
EP (1) EP1663266B1 (no)
JP (2) JP4808619B2 (no)
KR (1) KR101076209B1 (no)
AU (1) AU2004267928B2 (no)
BR (1) BRPI0413481A (no)
CA (1) CA2534791C (no)
DK (1) DK1663266T3 (no)
EA (1) EA009677B1 (no)
ES (1) ES2405934T3 (no)
MA (1) MA28072A1 (no)
MX (1) MXPA06001741A (no)
NO (1) NO20061138L (no)
NZ (1) NZ545594A (no)
PL (1) PL1663266T3 (no)
PT (1) PT1663266E (no)
WO (1) WO2005021015A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006117566A (ja) * 2004-10-20 2006-05-11 Asahi Breweries Ltd 糖代謝改善剤
JP2007195444A (ja) * 2006-01-26 2007-08-09 Asahi Food & Healthcare Ltd ダイエット飲食品
CN101528245A (zh) * 2006-08-24 2009-09-09 麒麟控股株式会社 用于改善皮肤状态的组合物
JP5238166B2 (ja) * 2007-02-02 2013-07-17 株式会社ヤクルト本社 インターロイキン１２産生抑制剤
FR2919187B1 (fr) * 2007-07-25 2009-11-27 Lesaffre & Cie Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
FR2949064B1 (fr) 2009-08-14 2011-10-07 Lesaffre & Cie Nouvelles compositions destinees a la prevention et/ou au traitement du diabete
FR2978967B1 (fr) * 2011-08-09 2020-03-20 Lesaffre Et Compagnie Ecorces de levure enrichies en vitamine d2, compositions les contenant, leur procede de preparation, leurs utilisations et dispositif permettant la mise en oeuvre du procede
MD4216C1 (ro) * 2012-08-15 2013-11-30 Институт Микробиологии И Биотехнологии Академии Наук Молдовы Tulpină de drojdii Saccharomyces cerevisiae - producătoare de manani
JP6932689B2 (ja) * 2016-04-14 2021-09-08 テーブルマーク株式会社 血糖値低下用又はｇｉ値低減用の食品組成物又は組み合わせ
WO2017199951A1 (ja) * 2016-05-17 2017-11-23 興人ライフサイエンス株式会社 糖尿病予防効果を有する酵母エキス
IT201600069379A1 (it) * 2016-07-04 2018-01-04 Prosol S P A Composizione sostanzialmente costituita da pareti cellulari di lievito e procedimento per la sua preparazione
EP3685681A1 (en) 2019-01-23 2020-07-29 Lesaffre et Compagnie A yeast product, and a composition comprising it, for use as a prebiotic agent

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5774072A (en) * 1980-10-29 1982-05-10 Yamanouchi Pharmaceut Co Ltd Granule of dietary fiber and its preparation
US4992540A (en) * 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
JPS61167622A (ja) * 1985-01-22 1986-07-29 Asahi Breweries Ltd 糖尿病コントロ−ル剤
US4962094A (en) * 1988-10-28 1990-10-09 Alpha Beta Technology, Inc. Glucan dietary additives
WO1996031128A1 (en) * 1993-12-28 1996-10-10 Societe Des Produits Nestle S.A. Cereal food product high in soluble fiber
DE4413023A1 (de) 1994-04-18 1995-10-19 Hoechst Ag Verfahren zur Gewinnung eines Faktors mit insulinartiger Wirkung aus Hefeextrakt
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
US5773426A (en) * 1996-06-07 1998-06-30 Masaki Shirota Proteoglucan and antidiabetic drug thereof
JP4441740B2 (ja) * 1996-09-25 2010-03-31 グレースリンク リミテッド β−グルカン製品および穀類からの抽出方法
DE19835767A1 (de) * 1998-08-07 2000-02-17 Kulicke Werner Michael Verfahren zur Gewinnung hochmolekularer biologisch aktiver immunmodulierender Polysaccharide aus Hefe Saccharomyces Cerevisiae
FR2800076B1 (fr) * 1999-10-22 2003-11-14 Lesaffre & Cie Mannoproteines solubles
EP1299424B1 (en) * 2000-07-03 2008-09-03 Granate Seed Limited COLD WATER SOLUBLE $g(b)-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME
KR20090057480A (ko) * 2001-04-27 2009-06-05 아지노모토 가부시키가이샤 면역강화제
FR2825004B1 (fr) * 2001-05-22 2005-02-11 Bio Springer Produit dietetique satiant
WO2002098440A1 (fr) * 2001-06-01 2002-12-12 Ajinomoto Co., Inc. Traitement antidiabetique
US20030118989A1 (en) * 2001-12-21 2003-06-26 Carsten Rosenow Differential isolation of cellular content for biological assays

Also Published As

Publication number Publication date
US20090022758A1 (en) 2009-01-22
ES2405934T3 (es) 2013-06-04
JP2011178794A (ja) 2011-09-15
KR101076209B1 (ko) 2011-10-24
NZ545594A (en) 2009-09-25
AU2004267928B2 (en) 2010-10-21
PL1663266T3 (pl) 2013-07-31
US20060257422A1 (en) 2006-11-16
EP1663266A1 (fr) 2006-06-07
US7459159B2 (en) 2008-12-02
DK1663266T3 (da) 2013-05-13
JP4808619B2 (ja) 2011-11-02
EA200600402A1 (ru) 2006-08-25
PT1663266E (pt) 2013-04-30
MXPA06001741A (es) 2006-05-12
MA28072A1 (fr) 2006-08-01
AU2004267928A1 (en) 2005-03-10
CA2534791C (fr) 2014-10-28
KR20060037432A (ko) 2006-05-03
EA009677B1 (ru) 2008-02-28
BRPI0413481A (pt) 2006-10-17
EP1663266B1 (fr) 2013-02-20
WO2005021015A1 (fr) 2005-03-10
CA2534791A1 (fr) 2005-03-10
JP2007501829A (ja) 2007-02-01

Similar Documents

Publication Publication Date Title
NO20061138L (no) Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi
NO20055832L (no) Fremstilling og anvendelse av arylalkylsyrederivater for behandling av fedme
MX349188B (es) Sns - 595 y metodos para utilizar el mismo.
MX2007005590A (es) Compuestos del inhibidor glicogeno fosforilasa y sus composiciones farmaceuticas.
EA200501095A1 (ru) Фенилацетамиды и их применение в качестве модуляторов глюкокиназы
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
DE60328476D1 (de) Medizinisches ballonsystem zur behandlung von adipositas
NO20061911L (no) Immunogene sammensetninger
NO20003233D0 (no) 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler
DE60330485D1 (de) Zur behandlung von diabetes
ATE485366T1 (de) Verwendung von lysyloxydase inhibitoren zur zellkultur und gewebeaufbau
DK1768490T3 (da) Systemer og fremgangsmåder til ex-vivo-organpleje
ATE447574T1 (de) 3-amino-4-phenylbutansäurederivate als dipeptidylpeptidase-hemmer zur behandlung oder vorbeugung von diabetes
NO20050717L (no) Metode og sammensetninger for modulering av T hjelpe (TH) celleutvikling og funksjon
ATE354563T1 (de) Sulfonderivate zur hemmung von gamma-secretase
ATE458731T1 (de) Pyrimidin-derivate zur behandlung von anormalem zellwachstum
DE60232245D1 (de) Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen
DE60329533D1 (de) Cyclische sulfamide zur inhibierung von gamma-sekretase
NO20075815L (no) Formuleringer og metoder for behandling av amyloidose
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
WO2003103581A3 (en) COMPOSITIONS AND METHODS FOR LIVER GROWTH AND PROTECTION
EA200702212A1 (ru) Способ лечения или профилактики разрушения кости или остеопороза
UA83057C2 (ru) Замещенные производные диоксида тиазолбензоизотиазола и их применение
NO20054670D0 (no) Behandling av intestinale tilstander med N-2,3,3-tetrametylbisyklo[2.2.1]-heptan-2-amid
NO20076405L (no) Anvendelse av 24-nor-UDCA

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application